# PPM1K

## Overview
PPM1K is a gene that encodes the protein phosphatase, Mg2+/Mn2+ dependent 1K, a mitochondrial serine/threonine phosphatase. This protein is a member of the PP2C family and is primarily involved in the regulation of branched-chain amino acid (BCAA) catabolism. Unlike other phosphatases that typically require magnesium ions, PPM1K is unique in its dependence on manganese ions for its enzymatic activity (Oyarzabal2012A; Kamada2020Metaldependent). The protein plays a critical role in dephosphorylating the branched-chain α-keto acid dehydrogenase complex (BCKDC), thereby facilitating the breakdown of BCAAs, which is essential for maintaining metabolic homeostasis (Tsansizi2016PPM1K). PPM1K is expressed in various tissues, with significant roles in cardiac and brain function, and its dysregulation is associated with metabolic disorders such as maple syrup urine disease (MSUD) and certain cancers (Lu2009Protein; Oyarzabal2012A).

## Structure
PPM1K is a mitochondrial matrix protein phosphatase that plays a crucial role in the regulation of branched-chain amino acid (BCAA) catabolism. The protein is a member of the PP2C family of serine/threonine phosphatases and is characterized by its dependence on manganese (Mn2+) ions for its phosphatase activity, rather than magnesium (Mg2+) (Oyarzabal2012A; Kamada2020Metaldependent). 

The primary structure of PPM1K consists of 372 amino acid residues, resulting in a protein with a predicted molecular weight of 40.9 kDa (Oyarzabal2012A). The protein contains a mitochondrial localization signal at the N-terminus, which directs it to the mitochondrial matrix (Kamada2020Metaldependent). 

While specific details on the secondary, tertiary, and quaternary structures of PPM1K are not provided, it is known that the protein shares structural features common to the PPM family, which includes a catalytic domain crucial for its function (Kamada2020Metaldependent). The protein's structure is adapted for specific interactions within the mitochondrial environment, particularly with the branched-chain α-ketoacid dehydrogenase complex (BCKDC) (Kamada2020Metaldependent). 

PPM1K is involved in the dephosphorylation of the BCKDC, which is essential for BCAA catabolism, and its activity is crucial for maintaining metabolic homeostasis (Tsansizi2016PPM1K).

## Function
PPM1K, also known as protein phosphatase 2Cm (PP2Cm), is a mitochondrial serine/threonine phosphatase that plays a critical role in the regulation of branched-chain amino acid (BCAA) catabolism. It is responsible for dephosphorylating the branched-chain α-keto acid dehydrogenase (BCKD) complex, thereby activating it and facilitating the breakdown of BCAAs such as leucine, isoleucine, and valine (Zhou2012Tissuespecific; Lu2009Protein). This process is essential for maintaining amino acid homeostasis and energy production in cells (Oyarzabal2012A).

PPM1K is highly expressed in the heart and brain, where it regulates the mitochondrial permeability transition pore, a key component in cell survival and cardiac function (Lu2007A; Kamada2020Metaldependent). The phosphatase activity of PPM1K is dependent on Mn2+ ions, distinguishing it from other phosphatases that typically require Mg2+ (Wynn2012Structural). Mutations in PPM1K can lead to defects in BCKD activity, contributing to metabolic disorders such as maple syrup urine disease (MSUD) (Lu2009Protein; Oyarzabal2012A). PPM1K's regulation by nutrient availability and its tissue-specific expression underscore its importance in metabolic homeostasis (Zhou2012Tissuespecific).

## Clinical Significance
Mutations and altered expression of the PPM1K gene have been implicated in several diseases. In pancreatic adenocarcinoma (PAAD), PPM1K is downregulated in tumor tissues and peripheral blood, correlating with poor prognosis and increased PD-L1 expression. Its knockdown promotes cancer cell proliferation and migration, suggesting a tumor suppressor role. PPM1K's expression is linked to immune cell infiltration and is considered a potential biomarker for PAAD (Zhuang2023Comprehensive).

In acute myeloid leukemia (AML), PPM1K regulates the ubiquitination of MEIS1 and p21 through CDC20, crucial for maintaining hematopoietic stem cell activities. Loss of PPM1K reduces leukemia-initiating cells and delays leukemogenesis, indicating its role in promoting leukemia development (Liu2018PPM1K).

PPM1K mutations are also associated with a mild variant of maple syrup urine disease (MSUD). A specific mutation, c.417_418delTA, leads to a truncated, nonfunctional protein, affecting the regulation of the branched-chain α-keto acid dehydrogenase complex and resulting in metabolic abnormalities (Oyarzabal2012A).

In cardiac health, PPM1K deficiency impairs branched-chain amino acid catabolism, leading to cardiac dysfunction and increased susceptibility to heart failure. This is linked to mitochondrial dysfunction and altered autophagic flux (Tsansizi2016PPM1K).

## Interactions
PPM1K is a mitochondrial serine/threonine phosphatase that plays a significant role in the regulation of branched-chain amino acid (BCAA) metabolism. It interacts with the branched-chain α-keto acid dehydrogenase complex (BCKDC), where it acts as the endogenous phosphatase. This interaction is crucial for the dephosphorylation and activation of BCKDC, thereby regulating BCAA degradation and maintaining metabolic homeostasis (Kamada2020Metaldependent).

PPM1K also interacts with CDC20, an E3 ubiquitin ligase, to regulate the ubiquitination and degradation of MEIS1 and p21. These interactions are important for maintaining the self-renewal and quiescence of hematopoietic stem cells (HSCs) and leukemia-initiating cells (LICs). The regulation of MEIS1 and p21 by PPM1K through CDC20-mediated ubiquitination is a key mechanism in hematopoiesis and leukemogenesis (Liu2018PPM1K).

In the context of pancreatic adenocarcinoma, PPM1K is involved in protein-protein interactions related to cell adhesion, growth, proliferation, and immune response. These interactions are part of its role in the tumor microenvironment and its potential as a tumor suppressor (Zhuang2023Comprehensive).


## References


[1. (Oyarzabal2012A) Alfonso Oyarzabal, Mercedes Martínez-Pardo, Begoña Merinero, Rosa Navarrete, Lourdes R Desviat, Magdalena Ugarte, and Pilar Rodríguez-Pombo. A novel regulatory defect in the branched-chain α-keto acid dehydrogenase complex due to a mutation in theppm1kgene causes a mild variant phenotype of maple syrup urine disease. Human Mutation, 34(2):355–362, December 2012. URL: http://dx.doi.org/10.1002/humu.22242, doi:10.1002/humu.22242. This article has 70 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1002/humu.22242)

[2. (Liu2018PPM1K) Xiaoye Liu, Feifei Zhang, Yaping Zhang, Xie Li, Chiqi Chen, Meiyi Zhou, Zhuo Yu, Yunxia Liu, Yuzheng Zhao, Xiaoxin Hao, Yabin Tang, Liang Zhu, Ligen Liu, Li Xie, Hao Gu, Hongfang Shao, Fangzhen Xia, Chunrong Yin, Minfang Tao, Jingjing Xie, Cheng Cheng Zhang, Yi Yang, Haipeng Sun, Guo-Qiang Chen, and Junke Zheng. Ppm1k regulates hematopoiesis and leukemogenesis through cdc20-mediated ubiquitination of meis1 and p21. Cell Reports, 23(5):1461–1475, May 2018. URL: http://dx.doi.org/10.1016/j.celrep.2018.03.140, doi:10.1016/j.celrep.2018.03.140. This article has 63 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.celrep.2018.03.140)

[3. (Tsansizi2016PPM1K) Lorenza Iolanda Tsansizi, Emilie Schrepfer, and Luca Scorrano. Ppm1k, a novel regulator of metabolism and autophagy in the heart. Biochimica et Biophysica Acta (BBA) - Bioenergetics, 1857:e101, August 2016. URL: http://dx.doi.org/10.1016/j.bbabio.2016.04.340, doi:10.1016/j.bbabio.2016.04.340. This article has 0 citations.](https://doi.org/10.1016/j.bbabio.2016.04.340)

[4. (Lu2009Protein) Gang Lu, Haipeng Sun, Pengxiang She, Ji-Youn Youn, Sarah Warburton, Peipei Ping, Thomas M. Vondriska, Hua Cai, Christopher J. Lynch, and Yibin Wang. Protein phosphatase 2cm is a critical regulator of branched-chain amino acid catabolism in mice and cultured cells. Journal of Clinical Investigation, 119(6):1678–1687, June 2009. URL: http://dx.doi.org/10.1172/jci38151, doi:10.1172/jci38151. This article has 178 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1172/jci38151)

[5. (Zhou2012Tissuespecific) Meiyi Zhou, Gang Lu, Chen Gao, Yibin Wang, and Haipeng Sun. Tissue-specific and nutrient regulation of the branched-chain α-keto acid dehydrogenase phosphatase, protein phosphatase 2cm (pp2cm). Journal of Biological Chemistry, 287(28):23397–23406, July 2012. URL: http://dx.doi.org/10.1074/jbc.m112.351031, doi:10.1074/jbc.m112.351031. This article has 56 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m112.351031)

[6. (Lu2007A) Gang Lu, Shuxun Ren, Paavo Korge, Jayoung Choi, Yuan Dong, James Weiss, Carla Koehler, Jau-nian Chen, and Yibin Wang. A novel mitochondrial matrix serine/threonine protein phosphatase regulates the mitochondria permeability transition pore and is essential for cellular survival and development. Genes &amp; Development, 21(7):784–796, March 2007. URL: http://dx.doi.org/10.1101/gad.1499107, doi:10.1101/gad.1499107. This article has 117 citations.](https://doi.org/10.1101/gad.1499107)

[7. (Kamada2020Metaldependent) Rui Kamada, Fuki Kudoh, Shogo Ito, Itsumi Tani, Jose Isagani B. Janairo, James G. Omichinski, and Kazuyasu Sakaguchi. Metal-dependent ser/thr protein phosphatase ppm family: evolution, structures, diseases and inhibitors. Pharmacology &amp; Therapeutics, 215:107622, November 2020. URL: http://dx.doi.org/10.1016/j.pharmthera.2020.107622, doi:10.1016/j.pharmthera.2020.107622. This article has 65 citations.](https://doi.org/10.1016/j.pharmthera.2020.107622)

[8. (Zhuang2023Comprehensive) Yanyan Zhuang, Sihua Lan, Wa Zhong, Fengting Huang, Juanfei Peng, and Shineng Zhang. Comprehensive analysis of ppms in pancreatic adenocarcinoma indicates the value of ppm1k in the tumor microenvironment. Cancers, 15(2):474, January 2023. URL: http://dx.doi.org/10.3390/cancers15020474, doi:10.3390/cancers15020474. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cancers15020474)

[9. (Wynn2012Structural) R. Max Wynn, Jun Li, Chad A. Brautigam, Jacinta L. Chuang, and David T. Chuang. Structural and biochemical characterization of human mitochondrial branched-chain α-ketoacid dehydrogenase phosphatase. Journal of Biological Chemistry, 287(12):9178–9192, March 2012. URL: http://dx.doi.org/10.1074/jbc.m111.314963, doi:10.1074/jbc.m111.314963. This article has 21 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m111.314963)